業績

業績
2022年

2022年

論文

"Human-Induced Pluripotent Stem Cell-Derived Cardiomyocyte Model for TNNT2 Δ160E-Induced Cardiomyopathy."
Kondo T, Higo S, Shiba M, Kohama Y, Kameda S, Tabata T, Inoue H, Okuno S, Ogawa S, Nakamura S, Takeda M, Ito E, Li J, Liu L, Kuramoto Y, Lee JK, Takashima S, Miyagawa S, Sawa Y, Hikoso S, Sakata Y.
Circulation: Genomic and Precision Medicine. 2022. Jul. 12. (2022).
- DOI: 10.1161/CIRCGEN.121.003522
"Editorial: Induced Pluripotent Stem Cell-Based Disease Modeling and Drug Discovery: Can We Recapitulate Cardiovascular Disease on a Culture Dish?"
Yuasa S, Yazawa M, Lee JK
Front. Cell Dev. Biol. 2022. Jan. 31. (2022).
- DOI: 10.3389/fcell.2021.831304

年別